Teleflex Total Liabilities 2010-2022 | TFX

Teleflex total liabilities from 2010 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Teleflex total liabilities for the quarter ending September 30, 2022 were $2.863B, a 15.35% decline year-over-year.
  • Teleflex total liabilities for 2021 were $3.117B, a 18.32% decline from 2020.
  • Teleflex total liabilities for 2020 were $3.816B, a 14.58% increase from 2019.
  • Teleflex total liabilities for 2019 were $3.331B, a 10.9% decline from 2018.
Teleflex Annual Total Liabilities
(Millions of US $)
2021 $3,117
2020 $3,816
2019 $3,331
2018 $3,738
2017 $3,751
2016 $1,754
2015 $1,861
2014 $2,009
2013 $2,293
2012 $1,952
2011 $1,941
2010 $1,856
2009 $2,254
Teleflex Quarterly Total Liabilities
(Millions of US $)
2022-09-30 $2,863
2022-06-30 $2,879
2022-03-31 $3,078
2021-12-31 $3,117
2021-09-30 $3,382
2021-06-30 $3,600
2021-03-31 $3,652
2020-12-31 $3,816
2020-09-30 $3,377
2020-06-30 $3,668
2020-03-31 $3,629
2019-12-31 $3,331
2019-09-30 $3,404
2019-06-30 $3,650
2019-03-31 $3,698
2018-12-31 $3,738
2018-09-30 $3,694
2018-06-30 $3,741
2018-03-31 $3,740
2017-12-31 $3,751
2017-09-30 $3,208
2017-06-30 $2,931
2017-03-31 $3,014
2016-12-31 $1,754
2016-09-30 $1,832
2016-06-30 $1,879
2016-03-31 $1,882
2015-12-31 $1,861
2015-09-30 $1,967
2015-06-30 $2,064
2015-03-31 $2,063
2014-12-31 $2,009
2014-09-30 $2,074
2014-06-30 $2,079
2014-03-31 $2,297
2013-12-31 $2,293
2013-09-30 $1,926
2013-06-30 $1,923
2013-03-31 $1,919
2012-12-31 $1,952
2012-09-30 $1,915
2012-06-30 $1,915
2012-03-31 $1,928
2011-12-31 $1,941
2011-09-30 $1,932
2011-06-30 $1,928
2011-03-31 $1,790
2010-12-31 $1,856
2010-09-30 $2,081
2010-06-30 $2,162
2010-03-31 $2,187
2009-12-31 $2,254
2009-09-30 $2,254
2009-06-30 $2,312
2009-03-31 $2,405
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $12.124B $2.810B
Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $230.517B 25.29
Edwards Lifesciences (EW) United States $50.772B 33.11
Alcon (ALC) Switzerland $37.369B 32.17
STERIS (STE) Ireland $21.864B 27.21
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.950B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00
Artivion (AORT) United States $0.566B 0.00